insights_auto
Why is PGEN up 2.76%?
Dive Deeperchevron_right
PGEN:NASDAQ
Precigen Inc
$7.81
arrow_upward
+2.76%(+0.21) 1D
$7.81
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 9, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PGEN...
Open
$7.60
High
$7.84
Low
$7.48
Mkt. cap
2.80B
Avg. vol.
4.81M
Volume
3.38M
52-wk high
$8.98
52-wk low
$2.99
EPS
-$1.10
Beta
0.92
Shares outstanding
358.04M
No. of employees
160
Open
$7.60
High
$7.84
Low
$7.48
Mkt. cap
2.80B
Avg. vol.
4.81M
Volume
3.38M
52-wk high
$8.98
52-wk low
$2.99
EPS
-$1.10
Beta
0.92
Shares outstanding
358.04M
No. of employees
160
News stories
From web sources and news partners
ChartMill
·
1 day ago
Friday's session: top gainers and losers in the dow jones index
The Motley Fool
·
4 hours ago
Prediction: This Is What a $5,000 Investment in the Vanguard S&P 500 ETF (VOO) Will Be Worth by 2040
The Washington Post
·
16 hours ago
How major US stock indexes fared Friday 10/9/2026
JournalArta
·
7 hours ago
Nasdaq rises tech shares as software: What to Know
Profile
Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari.
Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Wikipedia
About Precigen Inc
CEOHelen Sabzevari
Employees160
FoundedMay 21, 1998
Headquarters-
SectorBiotechnology
Websiteprecigen.com